Lessons from the initial adjuvant cyclophosphamide, methotrexate, and fluorouracil studies in operable breast cancer

被引：8
作者：
Bonadonna, Gianni [1 ]
Valagussa, Pinuccia [1 ]
Veronesi, Umberto [2 ]
机构：
[1] Ist Nazl Tumori, Carattere Sci ISt, Fdn Ist Ricovero & Cura, Dept Med Oncol, Milan, Italy
[2] European Inst Oncol, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 03期
关键词：
D O I：
10.1200/JCO.2007.13.8149
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：342 / 344
页数：3
相关论文
共 18 条
[1]   Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer [J].
Ayers, M ;
Symmans, WF ;
Stec, J ;
Damokosh, AI ;
Clark, E ;
Hess, K ;
Lecocke, M ;
Metivier, J ;
Booser, D ;
Ibrahim, N ;
Valero, V ;
Royce, M ;
Arun, B ;
Whitman, G ;
Ross, J ;
Sneige, N ;
Hortobagyi, GN ;
Pusztai, L .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (12) :2284-2293
[2]  
BONADON G, 1975, P AM ASSOC CANC RES, V16, P254
[3]   PRIMARY CHEMOTHERAPY TO AVOID MASTECTOMY IN TUMORS WITH DIAMETERS OF 3 CENTIMETERS OR MORE [J].
BONADONNA, G ;
VERONESI, U ;
BRAMBILLA, C ;
FERRARI, L ;
LUINI, A ;
GRECO, M ;
BARTOLI, C ;
DEYOLDI, GC ;
ZUCALI, R ;
RILKE, F ;
ANDREOLA, S ;
SILVESTRINI, R ;
DIFRONZO, G ;
VALAGUSSA, P .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (19) :1539-1545
[4]   30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study [J].
Bonadonna, G ;
Moliterni, A ;
Zambetti, M ;
Daidone, MG ;
Pilotti, S ;
Gianni, L ;
Valagussa, P .
BRITISH MEDICAL JOURNAL, 2005, 330 (7485) :217-220
[5]   Clinical relevance of different sequencing of doxorubicin and cyclophosphamide, methotrexate, and fluorouracil in operable breast cancer [J].
Bonadonna, G ;
Zambetti, M ;
Moliterni, A ;
Gianni, L ;
Valagussa, P .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (09) :1614-1620
[6]   COMBINATION CHEMOTHERAPY AS AN ADJUVANT TREATMENT IN OPERABLE BREAST-CANCER [J].
BONADONNA, G ;
BRUSAMOLINO, E ;
VALAGUSSA, P ;
ROSSI, A ;
BRUGNATELLI, L ;
BRAMBILLA, C ;
DELENA, M ;
TANCINI, G ;
BAJETTA, E ;
MUSUMECI, R ;
VERONESI, U .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (08) :405-410
[7]  
BONADONNA G, 1995, JAMA-J AM MED ASSOC, V273, P542
[8]  
BONADONNA G, 1975, CANCER CHEMOTH REP 3, V6, P381
[9]  
BONADONNA G, 2006, BREAST CANC A CLIN G
[10]   Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer [J].
Chang, JC ;
Wooten, EC ;
Tsimelzon, A ;
Hilsenbeck, SG ;
Gutierrez, MC ;
Elledge, R ;
Mohsin, S ;
Osborne, CK ;
Chamness, GC ;
Allred, DC ;
O'Connell, P .
LANCET, 2003, 362 (9381) :362-369
12